Sanctuary Advisors LLC Invests $1.83 Million in Aveanna Healthcare Holdings Inc. $AVAH

Sanctuary Advisors LLC purchased a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 214,153 shares of the company’s stock, valued at approximately $1,835,000. Sanctuary Advisors LLC owned approximately 0.10% of Aveanna Healthcare as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AVAH. Caitong International Asset Management Co. Ltd grew its position in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at approximately $43,000. Summit Securities Group LLC purchased a new stake in shares of Aveanna Healthcare during the 1st quarter worth approximately $53,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter worth approximately $64,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter worth approximately $69,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Trading Up 0.2%

Shares of Aveanna Healthcare stock opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $13.98. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The business has a 50 day moving average price of $9.95 and a 200 day moving average price of $8.03. The company has a market capitalization of $2.97 billion, a P/E ratio of 11.07, a P/E/G ratio of 0.85 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. Sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AVAH. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. BMO Capital Markets upped their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. UBS Group lifted their price target on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. Finally, Barclays boosted their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare has an average rating of “Moderate Buy” and a consensus price target of $12.89.

Insiders Place Their Bets

In related news, Director Rodney D. Windley sold 180,000 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $2,070,000.00. Following the sale, the director owned 2,078,017 shares of the company’s stock, valued at $23,897,195.50. This trade represents a 7.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 2,250,000 shares of Aveanna Healthcare stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the sale, the insider owned 12,315,892 shares of the company’s stock, valued at approximately $141,632,758. This represents a 15.45% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 79,746,745 shares of company stock valued at $773,117,091. Insiders own 5.30% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.